Reneo Pharmaceuticals, Inc. RPHM
Set alert
18.20 +18.20 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 60.84M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -47.89
- Beta
- 0.22
- Short ratio
- 27.39
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 11, 2024
- 50-d avg
- 14.92
- 200-d avg
- 16.09
- 1y target
- 2.25
Analyst view
Consensus: hold
Hold
Price target (mean) 2.25 -87.6% downside
Now 18.20
- Target (low)
- 1.50
- Target (mean)
- 2.25
- Target (high)
- 3.00
Recommendation trend
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.07 | -0.07 – -0.07 | -0.57 | +87.7% | 0 | 0.0% | 1 |
| Next quarter | -0.07 | -0.07 – -0.07 | -0.71 | +90.1% | 0 | 0.0% | 1 |
| Current year | -0.65 | -0.65 – -0.65 | -2.52 | +74.2% | 0 | 0.0% | 1 |
| Next year | 0.00 | 0.00 – 0.00 | -0.65 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 11, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 7, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 27, 2023 | HC Wainwright & Co. | Initiated | — | Buy |
| Jul 2, 2023 | B of A Securities | Initiated | — | Buy |
| May 17, 2022 | Piper Sandler | Maintained | — | Overweight |
| Mar 23, 2022 | SVB Leerink | Maintained | — | Outperform |
| Jan 26, 2022 | Baird | Initiated | — | Outperform |
| Dec 20, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Nov 21, 2021 | Ladenburg Thalmann | Initiated | — | Buy |
| May 3, 2021 | Piper Sandler | Initiated | — | Overweight |
| May 3, 2021 | Jefferies | Initiated | — | Buy |
| May 3, 2021 | SVB Leerink | Initiated | — | Outperform |